KIMS logo

Krishna Institute of Medical Sciences Limited Stock Price

NSEI:KIMS Community·₹321.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 26 Fair Values set on narratives written by author

KIMS Share Price Performance

₹804.25
180.45 (28.93%)
₹973.31
Fair Value
₹804.25
180.45 (28.93%)
17.4% undervalued intrinsic discount
₹973.31
Fair Value
Price ₹804.25
AnalystHighTarget ₹973.31
AnalystLowTarget ₹695.00
AnalystConsensusTarget ₹779.46

KIMS Community Narratives

·
Fair Value ₹973.31 17.4% undervalued intrinsic discount

Rising Urbanization And Insurance Growth Will Expand Healthcare Access

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value ₹695 15.7% overvalued intrinsic discount

Urban Expansion Will Trigger Integration Risks And Regulatory Hurdles

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value ₹779.46 3.2% overvalued intrinsic discount

New Facilities In India Will Unlock Rising Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative

Trending Discussion

Updated Narratives

KIMS logo

KIMS: Planned Equity Raise Will Support Future Upside Potential

Fair Value: ₹973.31 17.4% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
KIMS logo

KIMS: Fund Raising And Governance Moves Will Shape Steady Forward View

Fair Value: ₹695 15.7% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
KIMS logo

New Facilities In India Will Unlock Rising Healthcare Demand

Fair Value: ₹779.46 3.2% overvalued intrinsic discount
13 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Exceptional growth potential with low risk.

3 Risks
1 Reward

Krishna Institute of Medical Sciences Limited Key Details

₹39.0b

Revenue

₹14.9b

Cost of Revenue

₹24.1b

Gross Profit

₹21.7b

Other Expenses

₹2.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
6.03
61.82%
6.18%
126.8%
View Full Analysis

About KIMS

Founded
1973
Employees
5264
CEO
Abhinay Bollineni
WebsiteView website
www.kimshospitals.com

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services. In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke, TAVR/TAVI, hepatobiliary surgery, and trauma centers, as well as pain and wellness clinics. Further, it provides bariatric, thoracic, oral maxillofacial, and endovascular surgery services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Recent KIMS News & Updates

Narrative Update Jun 07

KIMS: Planned Equity Raise Will Support Future Upside Potential

Analysts have nudged their price target for Krishna Institute of Medical Sciences slightly higher from about ₹968 to ₹973, citing refreshed assumptions on the discount rate, revenue growth, profit margins and future P/E that feed into their updated fair value view. What's in the News Board meeting scheduled for May 15, 2026, at 14:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to address several governance items.
Narrative Update May 23

KIMS: Fund Raising And Governance Moves Will Shape Steady Forward View

Analysts have revised their price target on Krishna Institute of Medical Sciences from ₹650 to ₹695, citing updated assumptions around the discount rate, revenue growth, profit margin, and future P/E. What's in the News Board meeting scheduled for May 15, 2026 at 14:00 IST to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, along with several governance items, including appointment of cost auditors and senior management personnel (Board Meeting).

Recent updates

No updates